Scipher Medicine

Scipher Medicine

Scipher Medicine is a precision immunology company matching each patient with their most effective therapy.

Founded 2015

Waltham, United States 87 employees Series D Total: $227.00M Biotechnology, Health Care

Scipher Medicine is a precision immunology company that aims to revolutionize patient treatment. Founded in 2014, the company's slogan "Scipher Medicine is a precision immunology company matching each patient with their most effective therapy" reflects its core mission. The traditional approach to prescribing blockbuster therapies often leads to ineffective treatment for many patients, resulting in significant financial losses for the healthcare industry while patients continue to suffer. Scipher Medicine addresses this challenge by leveraging a platform that identifies the most suitable drug for a patient based on their fundamental disease biology, rather than relying on symptoms, disease classification, or medical bias. Through a simple test, they predict which drug a patient will respond to, ensuring the prescription of the most optimal treatment from the onset. The molecular data generated by their tests also fuel novel target discovery to address unmet medical needs in patients who do not respond to existing therapies. This innovative approach has attracted significant interest from investors, with the latest Series D investment of $110.00M secured on 24 February 2022. The investment was led by a consortium of prominent investors including Khosla Ventures, Optum Ventures, Alumni Ventures Blockchain Fund, aMoon, Cowen Digital, Green D Ventures, Hitachi Ventures, Laurion Capital, Monashee Investment Management, and Neuberger Berman. Operated out of the United States, Scipher Medicine operates within the Biotechnology and Health Care industries, positioning itself at the forefront of precision medicine and immunology. With its compelling value proposition and strong investor backing, Scipher Medicine is poised to drive significant impact in personalized patient care and address critical unmet medical needs.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	$110.00M	10	Khosla Ventures, Optum Ventures +8	24 Feb 2022
Series C	$82.00M	7	Khosla Ventures, aMoon +5	24 Mar 2021
Series B	Undisclosed	2	Optum Ventures, Tachyon Ventures	19 Feb 2020
Series B	$25.00M	4	Northpond Ventures, bpd partners a.s. +2	09 May 2019
Series A	$10.00M	3	Khosla Ventures, bpd partners a.s. +1	10 Sep 2018
Seed Round	Undisclosed	1	Granpool Innovative Investments	21 Apr 2016

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

$110.00M

Khosla Ventures, Optum Ventures +8

24 Feb 2022

Series C

$82.00M

Khosla Ventures, aMoon +5

24 Mar 2021

Series B

Undisclosed

Optum Ventures, Tachyon Ventures

19 Feb 2020

Series B

$25.00M

Northpond Ventures, bpd partners a.s. +2

09 May 2019

Series A

$10.00M

Khosla Ventures, bpd partners a.s. +1

10 Sep 2018

Seed Round

Undisclosed

Granpool Innovative Investments

21 Apr 2016

FAQ About Scipher Medicine

Scipher Medicine is a precision immunology company matching each patient with their most effective therapy.

Scipher Medicine was founded in 2015.

Scipher Medicine is headquartered in Waltham, United States.

Scipher Medicine operates in Biotechnology and Health Care. Its work centres on Precision medicine, Immunology, Drug response prediction and Healthcare platform.

Scipher Medicine has approximately 87 employees.

Scipher Medicine has completed 6 funding rounds, raising a total of $227.00M. The latest funding stage is Series D.

Top alternatives and competitors to Scipher Medicine include Alumis, ACEA Therapeutics, Inc, Coral (acquihired), Immunexpress Inc., MetaGenomika. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Scipher Medicine and Alumis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Scipher Medicine

Funding Rounds & Investors (6)

Scipher Medicine Alternatives & Competitors

FAQ About Scipher Medicine